Entrada Therapeutics (TRDA) Institutional Ownership $17.93 +0.16 (+0.90%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Entrada Therapeutics (NASDAQ:TRDA)CurrentInstitutional OwnershipPercentage86.39%Number ofInstitutional Buyers(last 12 months)30TotalInstitutional Inflows(last 12 months)$14.22MNumber ofInstitutional Sellers(last 12 months)10TotalInstitutional Outflows(last 12 months)$10.67M Get TRDA Insider Trade Alerts Want to know when executives and insiders are buying or selling Entrada Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TRDA Institutional Buying and Selling by Quarter Ad Porter & CompanyElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. Entrada Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC45,110$720K0.0%+210.6%0.121% 11/16/2024 Geode Capital Management LLC576,451$9.21M0.0%+8.8%1.540% 11/15/2024 Barclays PLC45,110$720K0.0%+210.6%0.121% 11/15/2024 Public Employees Retirement System of Ohio16,259$260K0.0%+89.1%0.043% 11/15/2024 XTX Topco Ltd39,670$634K0.0%N/A0.106% 11/15/2024 Jane Street Group LLC15,514$248K0.0%-42.0%0.041% Get the Latest News and Ratings for TRDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 Wellington Management Group LLP1,029,369$16.45M0.0%-0.4%2.751% 11/15/2024 State Street Corp469,601$7.50M0.0%+5.5%1.255% 11/15/2024 Jacobs Levy Equity Management Inc.201,803$3.23M0.0%+50.3%0.539% 11/15/2024 Janus Henderson Group PLC1,711,459$27.36M0.0%+10.5%4.574% 11/14/2024 Martingale Asset Management L P37,923$606K0.0%+36.9%0.101% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC14,156$226K0.0%+34.7%0.038% 11/13/2024 FMR LLC1,743,498$27.86M0.0%-4.7%4.659% 11/12/2024 Charles Schwab Investment Management Inc.185,984$2.97M0.0%+14.6%0.497% 11/12/2024 Massachusetts Financial Services Co. MA69,394$1.11M0.0%N/A0.185% 11/8/2024 Connor Clark & Lunn Investment Management Ltd.138,605$2.22M0.0%+132.4%0.370% 11/5/2024 GSA Capital Partners LLP36,577$585K0.0%+71.8%0.098% 11/4/2024 Los Angeles Capital Management LLC33,932$542K0.0%N/A0.091% 10/28/2024 US Bancorp DE2,658$42K0.0%N/A0.007% 10/23/2024 BayBridge Capital Group LLC29,039$464K0.3%N/A0.086% 10/19/2024 Allspring Global Investments Holdings LLC20,521$328K0.0%-25.7%0.055% 10/3/2024 SG Americas Securities LLC9,745$156K0.0%N/A0.026% 8/15/2024 The Manufacturers Life Insurance Company57,098$814K0.0%+3.9%0.169% 8/14/2024 Squarepoint Ops LLC25,950$370K0.0%-23.9%0.077% 8/14/2024 Marshall Wace LLP65,943$940K0.0%+27.5%0.195% 8/9/2024 Renaissance Technologies LLC44,600$636K0.0%N/A0.132% 8/8/2024 American Century Companies Inc.384,973$5.49M0.0%+5.1%1.140% 8/6/2024 Acadian Asset Management LLC13,367$190K0.0%+135.1%0.040% 8/1/2024 Rhumbline Advisers36,940$526K0.0%+25.3%0.109% 7/26/2024 Allspring Global Investments Holdings LLC27,631$394K0.0%+87.2%0.082% 7/26/2024 Bank of New York Mellon Corp125,436$1.79M0.0%+13.4%0.372% 5/16/2024 California State Teachers Retirement System12,631$179K0.0%-11.1%0.037% 5/15/2024 Price T Rowe Associates Inc. MD2,753,357$39.02M0.0%-8.5%8.156% 5/10/2024 Acadian Asset Management LLC5,685$79K0.0%N/A0.017% 5/10/2024 Vanguard Group Inc.1,078,908$15.29M0.0%+1.3%3.203% 5/7/2024 SG Americas Securities LLC7,687$109K0.0%-34.4%0.023% 4/30/2024 Allspring Global Investments Holdings LLC14,763$209K0.0%+427.6%0.044% 4/25/2024 New York State Teachers Retirement System1,915$27K0.0%N/A0.006% 4/18/2024 Allspring Global Investments Holdings LLC14,763$209K0.0%+427.6%0.044% 3/5/2024 Wellington Management Group LLP1,047,780$15.81M0.0%+0.2%3.140% Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW2/14/2024 72 Investment Holdings LLC172,600$2.61M11.6%-66.1%0.517% 2/13/2024 Tower Research Capital LLC TRC5,780$87K0.0%+476.3%0.017% 2/6/2024 Swiss National Bank23,000$347K0.0%-8.7%0.069% 1/30/2024 Strs Ohio24,100$363K0.0%+792.6%0.072% 1/12/2024 SG Americas Securities LLC11,714$177K0.0%+27.7%0.035% 12/1/2023 Wellington Management Group LLP1,045,652$16.52M0.0%+2.6%3.134% 11/15/2023 Redmile Group LLC1,284,000$20.29M1.0%-2.1%3.848% 11/14/2023 Corton Capital Inc.10,485$166K0.1%-42.0%0.031% 10/27/2023 Allspring Global Investments Holdings LLC2,798$44K0.0%N/A0.008% 10/27/2023 TD Asset Management Inc119,254$1.88M0.0%+100.0%0.359% 10/13/2023 SG Americas Securities LLC9,174$145K0.0%N/A0.028% 9/21/2023 Barclays PLC6,440$97K0.0%-37.0%0.019% 8/11/2023 Nan Fung Group Holdings Ltd49,082$743K0.5%-33.3%0.148% 8/4/2023 American International Group Inc.10,299$156K0.0%N/A0.031% 7/31/2023 Strs Ohio2,700$40K0.0%N/A0.008% 5/11/2023CHI Advisors LLC56,374$817K0.2%N/A0.170% 5/9/2023 Y Intercept Hong Kong Ltd10,188$148K0.0%N/A0.031% 2/14/2023 683 Capital Management LLC10,355$140K0.0%N/A0.033% 2/9/2023 Citigroup Inc.51,042$690K0.0%+3,124.4%0.163% 2/8/2023 Swiss National Bank26,500$358K0.0%N/A0.084% 11/15/2022 TCG Crossover Management LLC642,189$10.12M3.0%-3.2%2.045% 11/15/2022 Laurion Capital Management LP199,066$3.14M0.0%+54.2%0.634% 11/10/2022 Nan Fung Group Holdings Ltd141,593$2.23M1.4%-18.4%0.451% 11/7/2022 TD Asset Management Inc.59,496$925K0.0%+3.2%0.189% 8/15/2022 Laurion Capital Management LP129,066$1.57M0.0%N/A0.411% 5/27/2022 Walleye Capital LLC44,652$419K0.0%N/A0.142% 5/5/2022 New York State Common Retirement Fund4,880$46K0.0%N/A0.016% 2/18/2022 TCG Crossover Management LLC663,694$11.36M5.3%N/A2.126% 2/14/2022 Redmile Group LLC1,954,420$33.46M0.8%N/A6.262% 2/14/2022 72 Investment Holdings LLC509,024$8.71M7.7%N/A1.631% 2/14/2022 Suvretta Capital Management LLC106,000$1.82M0.0%N/A0.340% 2/14/2022 Ghisallo Capital Management LLC15,000$257K0.0%N/A0.048% 2/14/2022 Goldman Sachs Group Inc.7,626,182$130.56M0.0%N/A24.433% 2/11/2022 MPM Asset Management LLC4,425,784$75.77M16.4%N/A14.179% 2/10/2022 TD Asset Management Inc.57,675$987K0.0%N/A0.185% 2/8/2022 Northern Trust Corp79,483$1.36M0.0%N/A0.255% 2/3/2022 5AM Venture Management LLC4,408,379$75.47M14.2%N/A14.124% (Data available from 1/1/2016 forward) TRDA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRDA shares? During the previous two years, 46 institutional investors and hedge funds held shares of Entrada Therapeutics. The most heavily invested institutionals were Price T Rowe Associates Inc. MD ($39.02M), FMR LLC ($27.86M), Janus Henderson Group PLC ($27.36M), Redmile Group LLC ($20.29M), Wellington Management Group LLP ($16.45M), Vanguard Group Inc. ($15.29M), and Geode Capital Management LLC ($9.21M).Learn more on TRDA's institutional investors. What percentage of Entrada Therapeutics stock is owned by institutional investors? 86.39% of Entrada Therapeutics stock is owned by institutional investors. Learn more on TRDA's institutional investor holdings. Which institutional investors have been buying Entrada Therapeutics stock? Of the 37 institutional investors that purchased Entrada Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($161.96K), Connor Clark & Lunn Investment Management Ltd. ($78.95K), Massachusetts Financial Services Co. MA ($69.39K), Jacobs Levy Equity Management Inc. ($67.56K), Barclays PLC ($61.17K), TD Asset Management Inc ($59.63K), and CHI Advisors LLC ($56.37K). How much institutional buying is happening at Entrada Therapeutics? Institutional investors have bought a total of 1,147,601 shares in the last 24 months. This purchase volume represents approximately $17.68M in transactions. Which Entrada Therapeutics major shareholders have been selling company stock? Of the 14 institutional investors that sold Entrada Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: 72 Investment Holdings LLC ($336.42K), Price T Rowe Associates Inc. MD ($256.32K), FMR LLC ($85.67K), Redmile Group LLC ($27.57K), Nan Fung Group Holdings Ltd ($24.50K), Jane Street Group LLC ($11.24K), and Squarepoint Ops LLC ($8.15K). How much institutional selling is happening at Entrada Therapeutics? Institutional investors have sold a total of 780,713 shares in the last 24 months. This volume of shares sold represents approximately $11.66M in transactions. Related Companies Scholar Rock Major Shareholders Zai Lab Major Shareholders Amneal Pharmaceuticals Major Shareholders Janux Therapeutics Major Shareholders Catalyst Pharmaceuticals Major Shareholders Iovance Biotherapeutics Major Shareholders Twist Bioscience Major Shareholders Longboard Pharmaceuticals Major Shareholders Arrowhead Pharmaceuticals Major Shareholders Protagonist Therapeutics Major Shareholders This page (NASDAQ:TRDA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entrada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entrada Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRDA Stock Alerts